Cargando…

Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: A survey

BACKGROUND: Substance use and substance use disorders are common in people who experience detention or incarceration in Canada, and opioid agonist treatment (OAT) may reduce the harms associated with substance use disorders. We aimed to define current physician practice in provincial correctional fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kouyoumdjian, Fiona G., Patel, Alexandra, To, Matthew J., Kiefer, Lori, Regenstreif, Leonora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813939/ https://www.ncbi.nlm.nih.gov/pubmed/29447177 http://dx.doi.org/10.1371/journal.pone.0192431

Ejemplares similares

Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015–2018: a repeated cross-sectional analysis
por: Bodkin, Claire, et al.
Publicado: (2021)

Access to primary care in adults in a provincial correctional facility in Ontario
por: Green, Samantha, et al.
Publicado: (2016)

Erratum to: Access to primary care in adults in a provincial correctional facility in Ontario
por: Green, Samantha, et al.
Publicado: (2016)

Burden of opioid toxicity death in the fentanyl-dominant era for people who experience incarceration in Ontario, Canada, 2015–2020: a whole population retrospective cohort study
por: Butler, Amanda, et al.
Publicado: (2023)

Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
por: Regenstreif, Lori, et al.
Publicado: (2022)

“When you first walk out the gates…where do [you] go?”: Barriers and opportunities to achieving continuity of health care at the time of release from a provincial jail in Ontario
por: Hu, Catherine, et al.
Publicado: (2020)

The impact of cannabis use on patients enrolled in opioid agonist therapy in Ontario, Canada
por: Franklyn, Alexandra M., et al.
Publicado: (2017)

Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

Primary care utilization in people who experience imprisonment in Ontario, Canada: a retrospective cohort study
por: Kouyoumdjian, Fiona G., et al.
Publicado: (2018)

Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021
por: Rosic, Tea, et al.
Publicado: (2023)

Evaluating the effectiveness of concurrent opioid agonist treatment and physician-based mental health services for patients with mental disorders in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2020)

Validating emergency department cardioversion procedures in provincial administrative data in Ontario, Canada
por: Atzema, Clare L., et al.
Publicado: (2022)

The health care utilization of people in prison and after prison release: A population-based cohort study in Ontario, Canada
por: Kouyoumdjian, Fiona G., et al.
Publicado: (2018)

Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2021)

Opioid agonist treatment take-home doses (‘carries’): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?
por: Russell, Cayley, et al.
Publicado: (2022)

Quality of Antenatal Care for Women Who Experience Imprisonment in Ontario, Canada
por: Carter Ramirez, Alison, et al.
Publicado: (2020)

Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada
por: Burden, A. M., et al.
Publicado: (2011)

Cervical Cancer Screening Access for Women Who Experience Imprisonment in Ontario, Canada
por: Kouyoumdjian, Fiona G., et al.
Publicado: (2018)

Disparities in Physician Compensation by Gender in Ontario, Canada
por: Steffler, Mitch, et al.
Publicado: (2021)

Measuring the Burden of Opioid-related Mortality in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

The opioid crisis: past, present and future policy climate in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2017)

The characteristics of stroke units in Ontario: a pan-provincial survey
por: Rac, Valeria E., et al.
Publicado: (2017)

Rhinovirus Outbreaks in Long-term Care Facilities, Ontario, Canada
por: Longtin, Jean, et al.
Publicado: (2010)

Suitability of bovine portion condemnations at provincially-inspected abattoirs in Ontario Canada for food animal syndromic surveillance
por: Alton, Gillian D, et al.
Publicado: (2012)

The Embodiment of Contempt: Ontario Provincial Prison Food
por: Struthers Montford, Kelly
Publicado: (2022)

Reproductive healthcare in prison: A qualitative study of women’s experiences and perspectives in Ontario, Canada
por: Liauw, Jessica, et al.
Publicado: (2021)

Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada
por: Morin, Kristen A., et al.
Publicado: (2019)

Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2021)

Drug Toxicity Deaths after Release from Incarceration in Ontario, 2006-2013: Review of Coroner’s Cases
por: Groot, Emily, et al.
Publicado: (2016)

Critical appraisal skills of family physicians in Ontario, Canada
por: Godwin, Marshall, et al.
Publicado: (2003)

Prevalence of Prenatal Opioid Exposure in Ontario, Canada, 2014-2019
por: Camden, Andi, et al.
Publicado: (2021)

Variability in changes in physician outpatient antibiotic prescribing from 2019 to 2021 during the COVID-19 pandemic in Ontario, Canada
por: Tandon, Pranav, et al.
Publicado: (2023)

Establishing a Provincial Registry for Recurrent Prostate Cancer: Providing Access to PSMA PET/CT in Ontario, Canada
por: Young, Sympascho, et al.
Publicado: (2021)

Does Variation among Provincial Drug Formulary Antimicrobial Listings in Canada Influence Prescribing Rates?
por: Glass-Kaastra, Shiona K., et al.
Publicado: (2014)

Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada
por: Martins, Diana, et al.
Publicado: (2022)

The Role of the Medical School Training on Physician Opioid Prescribing Practices: Evidence from Ontario, Canada: Le rôle de la formation à la faculté de médecine à l’égard des pratiques de prescription d’opioïdes des médecins: données probantes d’Ontario, Canada
por: de Oliveira, Claire, et al.
Publicado: (2020)

Correction to: Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada
por: Morin, Kristen A., et al.
Publicado: (2019)

Measuring treatment attrition at various stages of engagement in Opioid Agonist Treatment in Ontario Canada using a cascade of care framework
por: Tahsin, Farah, et al.
Publicado: (2022)

Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
por: Russell, Cayley, et al.
Publicado: (2022)

An Evaluation of Provincial Infectious Disease Surveillance Reports in Ontario
por: Chan, Ellen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5oqs7kd51hdtkd4acv34frs9e0